MICROBIOTIX, INC.
US UEI SCNKBDM341T1 · SME
89public awards
$80.3Mtotal public funding
2026-08-03latest award
State aid awards (89)
| Date | Amount | Type | Programme | Granted by |
|---|---|---|---|---|
| 2026-08-03 | $588k | Grant | ALLERGY AND INFECTIOUS DISEASES RESEARCH | Department of Health and Human Services |
| 2026-07-16 | $600k | Grant | ALLERGY AND INFECTIOUS DISEASES RESEARCH | Department of Health and Human Services |
| 2026-05-19 | $1.9M | Grant | ALLERGY AND INFECTIOUS DISEASES RESEARCH | Department of Health and Human Services |
| 2026-01-29 | $1.3M | Grant | VISION RESEARCH | Department of Health and Human Services |
| 2025-09-22 | $300k | Grant | Novel Benzyl-Piperidine antifungal agents to treat intractable Mucoral | Department of Health and Human Services |
| 2025-08-08 | $299k | Grant | Development of well tolerated novel Inhibitors of drug resistant CMV | Department of Health and Human Services |
| 2025-05-16 | $977k | Grant | Discovery of Bunyaviral Endonuclease Inhibitors for Anti Viral | Department of Health and Human Services |
| 2024-04-12 | $600k | Grant | Proof of concept experiments for T3SS inhibitors against burn wound in | Department of Health and Human Services |
| 2023-08-21 | $587k | Grant | Development of antibody drug conjugates as pan-filo antivirals | Department of Health and Human Services |
| 2022-08-12 | $569k | Grant | Discovery of Bunyaviral Endonuclease Inhibitors for Antiviral Therapy | Department of Health and Human Services |
| 2022-07-01 | $300k | Grant | Type 3 secretion system inhibitors to treat Pseudomonas aeruginosa ker | Department of Health and Human Services |
| 2021-06-01 | $1.5M | Grant | Development of Filociclovir for the Treatment of Ocular Adenoviral Inf | Department of Health and Human Services |
| 2021-02-03 | $3.0M | Grant | Screening for rAAV transduction enhancers | Department of Health and Human Services |
| 2020-09-08 | $585k | Grant | Development of a novel broad-spectrum inhibitor of non-polio enterovir | Department of Health and Human Services |
| 2020-08-01 | $599k | Grant | Inhibitors of T3SS translocon assembly to combat multi-drug resistant | Department of Health and Human Services |
| 2020-07-21 | $597k | Grant | Development of a New Class of Hepatitis B Virus Inhibitors that Induce | Department of Health and Human Services |
| 2019-12-09 | $600k | Grant | Discovery of Enterovirus D68 2A protease inhibitors for antiviral ther | Department of Health and Human Services |
| 2019-08-21 | $3.0M | Grant | Novel Spectinamide Antibiotics for the Treatment of MDR/XDR Tuberculos | Department of Health and Human Services |
| 2019-08-20 | $3.0M | Grant | Optimization of novel pyranopyridine efflux pump inhibitors | Department of Health and Human Services |
| 2018-12-14 | $3.0M | Grant | Novel Plasmodial Surface Anion Channel Inhibitors as Antimalarial Drug | Department of Health and Human Services |
| 2018-09-04 | $598k | Grant | Novel Small Molecule Therapeutics Inhibiting Zika Virus Infection | Department of Health and Human Services |
| 2018-08-13 | $585k | Grant | Discovery of Zika virus therapeutics using a replicon assay | Department of Health and Human Services |
| 2018-08-01 | $597k | Grant | EF-Tu binding Tetrazoles targeting MDR Neisseria gonorrhoeae | Department of Health and Human Services |
| 2018-02-08 | $600k | Grant | Synergistic panfiloviral entry inhibiting antibody drug conjugates | Department of Health and Human Services |
| 2018-01-15 | $596k | Grant | Inhibitors of virus glycoprotein-LAMP1 receptor binding for Lassa viru | Department of Health and Human Services |
| 2017-09-01 | $433k | Grant | Development of small molecule TLR5 inhibitors for rheumatoid arthritis | Department of Health and Human Services |
| 2017-08-18 | $586k | Grant | Aminospectinomycin antibacterials for the treatment of antibiotic-resi | Department of Health and Human Services |
| 2017-06-01 | $594k | Grant | Inhibitors of Pseudomonas aeruginosa efflux pumps to combat multi-drug | Department of Health and Human Services |
| 2017-01-27 | $591k | Grant | Screening for rAAV transduction enhancers | Department of Health and Human Services |
| 2016-08-19 | $601k | Grant | T SS needle protein inhibitors for the treatment of P aeruginosa infe | Department of Health and Human Services |
| 2016-08-01 | $585k | Grant | Inhibitors of the viral nucleoprotein polymerase co factor interaction | Department of Health and Human Services |
| 2016-06-24 | $602k | Grant | Novel beta lactams as inhibitors of ebola virus infections | Department of Health and Human Services |
| 2015-08-01 | $597k | Grant | GPCR antagonists as anti-Ebola virus entry inhibitors | Department of Health and Human Services |
| 2015-06-15 | $570k | Grant | Antibiotic potentiators maximizing the formation of open- channel OprF | Department of Health and Human Services |
| 2015-03-01 | $577k | Grant | Novel filovirus entry inhibitors based on a pseudo-symmetrical bipheny | Department of Health and Human Services |
| 2015-02-10 | $2.5M | Grant | Optimization of novel pyranopyridine efflux pump inhibitors | Department of Health and Human Services |
| 2015-02-01 | $577k | Grant | Lipoprotein synthesis inhibitors for multi-drug resistant Gram-negativ | Department of Health and Human Services |
| 2015-01-01 | $1.3M | Grant | Novel Plasmodial Surface Anion Channel Inhibitors as Antimalarial Drug | Department of Health and Human Services |
| 2014-07-07 | $591k | Grant | Small Molecule Inhibitors of trans-Translation with Broad Spectrum Ant | Department of Health and Human Services |
| 2014-06-15 | $3.0M | Grant | Novel spectinamide antibiotics for the treatment of MDR/XDR tuberculos | Department of Health and Human Services |
| 2014-05-08 | $583k | Grant | Novel Inhibitors Targeting Early Steps of Human Cytomegalovirus Replic | Department of Health and Human Services |
| 2014-02-15 | $598k | Grant | New small molecule inhibitors of arenaviruses | Department of Health and Human Services |
| 2014-02-15 | $600k | Grant | New heterocyclic inhibitors of filoviruses | Department of Health and Human Services |
| 2013-01-01 | $600k | Grant | Medical Images, HTML5, and Clinical Trial Remote Collaboration | Department of Health and Human Services |
| 2013-01-01 | $600k | Grant | Aminoglycoside potentiators for P. aeruginosa therapy | Department of Health and Human Services |
| 2012-01-01 | $596k | Grant | Novel Plasmodial Surface Anion Channel Inhibitors as Antimalarial Drug | Department of Health and Human Services |
| 2012-01-01 | $565k | Grant | Optimization of novel pyranopyridine efflux pump inhibitors | Department of Health and Human Services |
| 2012-01-01 | $2.9M | Grant | Identification of Novel Broad Spectrum Influenza Virus Inhibitors | Department of Health and Human Services |
| 2012-01-01 | $168k | Grant | Novel aryl-rhodanine inhibitors of Streptococcus mutans biofilms | Department of Health and Human Services |
| 2012-01-01 | $3.0M | Grant | Novel Methylenecyclopropane Analogues as Anti-Human Herpesvirus 6 and | Department of Health and Human Services |
| 2012-01-01 | $581k | Grant | Inhibitors of S. aureus bNOS for adjunctive therapy | Department of Health and Human Services |
| 2012-01-01 | $585k | Grant | Novel Spectinamide Antibiotics for the Treatment of MDR/XDR Tuberculos | Department of Health and Human Services |
| 2012-01-01 | $595k | Grant | Inhibitors of wall teichoic acid biosynthesis of Staphylococcus aureus | Department of Health and Human Services |
| 2011-01-01 | $3.0M | Grant | Type III Secretion Inhibitors for Anti-Infective Therapy | Department of Health and Human Services |
| 2011-01-01 | $600k | Grant | A NOVEL BIS-INDOLE COMPOUND AGAINST CATHETER COLONIZATION | Department of Health and Human Services |
| 2011-01-01 | $600k | Grant | Quinoline-based Inhibitors of BoNT/A LC | Department of Health and Human Services |
| 2010-01-01 | $600k | Grant | Structure-Based Design of Sortase Inhibitors for Anti-Infective Therap | Department of Health and Human Services |
| 2009-01-01 | $521k | Grant | Novel Antibacterials Targeting Gram-negative Nonfermenters | Department of Health and Human Services |
| 2009-01-01 | $599k | Grant | Carbocyclic nucleosides as therapeutics for Ebola infections | Department of Health and Human Services |
| 2009-01-01 | $1.8M | Grant | DNA HELICASE AND PRIMASE INHIBITORS FOR BIODEFENSE | Department of Health and Human Services |
| 2009-01-01 | $634k | Grant | Novel Methylenecyclopropane Analogues as Anti-Human Herpesvirus 6 and | Department of Health and Human Services |
| 2009-01-01 | $562k | Grant | Inhibitors of the Y. pestis cell surface plasminogen activator for bio | Department of Health and Human Services |
| 2008-01-01 | $489k | Grant | Identification of Novel Broad Spectrum Influenza Virus Inhibitors | Department of Health and Human Services |
| 2008-01-01 | $600k | Grant | Antibiotic Potentiators Targeting SOS Induction | Department of Health and Human Services |
| 2008-01-01 | $294k | Grant | Bacterial DnaA Initiator Protein: A Target for Novel Antibiotics | Department of Health and Human Services |
| 2008-01-01 | $592k | Grant | Therapeutics targeting fatty acid synthesis in P. aeruginosa | Department of Health and Human Services |
| 2008-01-01 | $2.2M | Grant | A Potent Oral Therapy for Cytomegalovirus Infection | Department of Health and Human Services |
| 2007-01-01 | $294k | Grant | Quinoline-Based Inhibitors of Botulinum Neurotoxin A | Department of Health and Human Services |
| 2007-01-01 | $300k | Grant | Inhibition of Ebola Virus Infection with Cathepsin L Inhibitors | Department of Health and Human Services |
| 2007-01-01 | $193k | Grant | Novel Inhibitors of Staphylococcal Biofilm Formation | Department of Health and Human Services |
| 2007-01-01 | $300k | Grant | TLR5 Antagonists for Infectious Disease Therapy | Department of Health and Human Services |
| 2006-01-01 | $654k | Grant | Type III Secretion Inhibitors for Anti-Infective Therapy | Department of Health and Human Services |
| 2006-01-01 | $720k | Grant | Identification of Ebola Virus Entry Inhibitors | Department of Health and Human Services |
| 2006-01-01 | $3.2M | Grant | Discovery of B. pseudomallei therapeutics for Biodefense | Department of Health and Human Services |
| 2006-01-01 | $368k | Grant | c-diGMP Signal Transduction Proteins are Biofilm Drug Targets | Department of Health and Human Services |
| 2006-01-01 | $515k | Grant | DEVELOPMENT OF INHIBITORS OF MYCOBACTERIUM TUBERCULOSIS DNA REPLICATIO | Department of Health and Human Services |
| 2006-01-01 | $371k | Grant | Identification of HCV E1 an E2 Inhibitors | Department of Health and Human Services |
| 2005-01-01 | $1.1M | Grant | DNA helicase and primase inhibitors for biodefense | Department of Health and Human Services |
| 2005-01-01 | $305k | Grant | THERAPEUTIC APPROACHES TO BIOFILM ANTIBIOTIC RESISTANCE | Department of Health and Human Services |
| 2005-01-01 | $387k | Grant | DEVELOPMENT OF SCREENS FOR BACILLUS ANTHRACIS TARGETS | Department of Health and Human Services |
| 2005-01-01 | $369k | Grant | Sensing Biowarfare Agents by Surface Enhanced Raman | Department of Health and Human Services |
| 2005-01-01 | $261k | Grant | BACTERIAL DNA HELICASES: TARGETS FOR NOVEL ANTIBIOTICS | Department of Health and Human Services |
| 2005-01-01 | $1.4M | Grant | Small Molecule Inhibitors of Anthrax Lethal Factor | Department of Health and Human Services |
| 2004-01-01 | $1.5M | Grant | NMSO3: A NOVEL THERAPY FOR RESPIRATORY SYNCYTIAL VIRUS | Department of Health and Human Services |
| 2004-01-01 | $0 | Grant | BACTERIAL DNA POLYMERASES: TARGET FOR NOVEL ANTIBIOTICS | Department of Health and Human Services |
| 2004-01-01 | $1.4M | Grant | Novel Therapies for BioFilm-Related Infections | Department of Health and Human Services |
| 2003-01-01 | $304k | Grant | A POTENT ORAL THERAPY FOR CYTOMEGALOVIRUS INFECTION | Department of Health and Human Services |
| 2003-01-01 | $399k | Grant | A NOVEL THERAPY FOR RESPIRATORY SYNCYTIAL VIRUS | Department of Health and Human Services |
| 2001-01-01 | $224k | Grant | BACTERIAL DNA POLYMERASES: TARGETS FOR NOVEL ANTIBIOTIC | Department of Health and Human Services |
Want an alert when companies like this one get funded in your sector? Pro waitlist →